NCT01106508View on ClinicalTrials.gov

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Advanced Solid TumorsRecurrent or Refractory MedulloblastomaLocally Advanced or Metastatic Basal Cell Carcinoma
Interventions
DRUG

LEQ506

Trial Locations (5)

8091

Novartis Investigative Site, Zurich

10021

Memorial Sloan Kettering Cancer Center, New York

90095

University of California at Los Angeles UCLA LeConte Location, Los Angeles

3584CX

Novartis Investigative Site, Utrecht

OX3 7LJ

Novartis Investigative Site, Oxford

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY